Molecular and Cellular Biologists in Boston-Cambridge-Newton, MA-NH

Employers filed 619 applications covering 697 positions for this role here, at a median of $113,464 a year. 385 of those state a minimum and no maximum — a Labor Condition Application commits an employer to a floor, not to a salary.

What the government requires here

The prevailing wage for Molecular and Cellular Biologists in Boston-Cambridge-Newton, MA-NH, wage year 2025-26 — the four levels an employer must meet depending on the experience the role demands.

Level	Who it is for	A year
Level I	Entry: a role needing basic understanding and close supervision	$70,470
Level II	Qualified: some experience, moderate supervision	$91,978
Level III	Experienced: sound understanding, limited supervision	$113,464
Level IV	Fully competent: judgement, may supervise others	$134,971

Who filed, and at what

Employer	Level	Filings	Positions	Median
Dana-Farber Cancer Institute	Level I	74	130	$75,000
The Broad Institute, Inc.	Level I	30	30	$79,178
Children's Hospital Corporation	Level II	30	30	$77,267
Harvard University	Level I	29	29	$76,000
Novartis Institutes for BioMedical Research, Inc.	Level II	17	17	$91,978
Vertex Pharmaceuticals Incorporated	Level II	14	14	$91,978
TRUSTEES OF BOSTON UNIVERSITY	Level I	13	13	$70,000
Dana-Farber Cancer Institute	Level II	12	12	$90,000
Eli Lilly and Company	Level IV	12	16	$190,000
Harvard University	Level II	12	12	$87,205
The Broad Institute, Inc.	Level II	11	11	$110,000
The Broad Institute, Inc.	Level III	9	9	$123,000
Howard Hughes Medical Institute	Level II	9	9	$79,000
Whitehead Institute for Biomedical Research	Level I	9	9	$74,500
Beth Israel Deaconess Medical Center,Inc.	Level I	7	7	$67,824
Novartis Institutes for BioMedical Research, Inc.	Level III	7	7	$113,464
Bristol-Myers Squibb Company	Level III	6	6	$161,396
Children's Hospital Corporation	Level III	6	6	$99,100
AbbVie Bioresearch Center Inc.	Level IV	5	5	$143,637
Boston Children's Network Specialty Physicians, Inc	Level II	5	5	$80,357
Foghorn Therapeutics, Inc	Level IV	5	5	$134,971
Regeneron Pharmaceuticals, Inc.	Level II	5	23	$124,200
Wave Life Sciences USA, Inc.	Level III	5	5	$115,700
ZIFO TECHNOLOGIES, INC.	Level I	5	5	$87,447
Brigham and Women's Hospital	Level III	4	4	$107,525
General Hospital Corporation	Level III	4	4	$88,899
Intellia Therapeutics, Inc.	Level III	4	4	$126,250
Massachusetts Institute of Technology	Level I	4	4	$74,500
Tufts University	Level I	4	4	$69,505
AbbVie Bioresearch Center Inc.	Level III	3	3	$128,000
AstraZeneca Pharmaceuticals LP	Level III	3	3	$145,000
Bayer HealthCare Pharmaceuticals Inc.	Level I	3	3	$110,000
Boston College	Level I	3	3	$70,040
The Broad Institute, Inc.	Level IV	3	3	$175,000
DREAM Venture Labs Inc.	Level II	3	3	$91,978
General Hospital Corporation	Level I	3	3	$61,381
Generate Biomedicines, Inc.	Level II	3	3	$95,000
Generate Biomedicines, Inc.	Level IV	3	3	$154,000
Institute for Protein Innovation Inc.	Level II	3	3	$75,130
Intellia Therapeutics, Inc.	Level IV	3	3	$147,400
ModernaTX, Inc.	Level III	3	3	$153,900
ModernaTX, Inc.	Level IV	3	3	$145,900
Novartis Institutes for BioMedical Research, Inc.	Level IV	3	3	$134,971
Somite Therapeutics, Inc.	Level III	3	3	$125,000
Takeda Development Center Americas, Inc.	Level II	3	3	$110,451
TreeFrog Therapeutics, Inc.	Level II	3	3	$91,978
Vertex Pharmaceuticals Incorporated	Level III	3	3	$113,464
ZIFO TECHNOLOGIES, INC	Level II	3	3	$94,554
AbbVie Bioresearch Center Inc.	Level II	2	2	$99,659
Active Site Research, Inc.	Level II	2	2	$85,000
The ADA Forsyth Institute	Level I	2	2	$61,381
Alloy Therapeutics, Inc.	Level I	2	2	$98,250
Alnylam US, Inc.	Level II	2	2	$141,500
Amgen Inc.	Level II	2	2	$121,821
Apriori Bio, Inc.	Level II	2	2	$95,000
Asimov, Inc.	Level III	2	2	$124,639
AstraZeneca Pharmaceuticals LP	Level I	2	2	$105,659
AstraZeneca Pharmaceuticals LP	Level II	2	2	$131,203
AutoIVF, Inc.	Level II	2	2	$96,255
Biocytogen Boston Corp.	Level II	2	2	$105,000
Biocytogen Boston Corp.	Level III	2	2	$117,000
BlueRock Therapeutics, LP	Level III	2	2	$121,232
Brandeis University	Level I	2	2	$73,942
Breaking, Inc.	Level I	2	2	$75,000
Brigham and Women's Hospital	Level I	2	2	$68,191
Brigham and Women's Hospital	Level IV	2	2	$133,281
Children's Hospital Pediatric Associates, Inc.	Level III	2	2	$130,603
eGenesis Inc.	Level II	2	2	$116,800
Eli Lilly and Company	Level III	2	2	$126,270
Entrada Therapeutics, Inc.	Level IV	2	2	$142,550
Foundation Medicine, Inc.	Level II	2	2	$91,978
General Hospital Corporation	Level II	2	2	$94,950
Generate Biomedicines, Inc.	Level III	2	2	$117,500
Genetix Biotherapeutics Inc.	Level III	2	2	$174,600
Harbinger Health, Inc.	Level III	2	2	$117,083
IM PRO MAKEUP NY LP	Level II	2	2	$105,000
IM PRO MAKEUP NY LP	Level IV	2	2	$163,500
Janssen Research & Development, LLC	Level II	2	2	$156,150
Kelonia Therapeutics, Inc.	Level III	2	2	$123,449
Lonza Biologics Inc.	Level II	2	2	$119,643
Merck Research Laboratories Massachusetts, LLC	Level II	2	2	$131,950
ModernaTX, Inc.	Level II	2	2	$111,350
Novartis Institutes for BioMedical Research, Inc.	Level I	2	2	$70,470
Obsidian Therapeutics, Inc.	Level II	2	2	$106,706
QLD Biotherapeutics Inc.	Level III	2	2	$128,450
Red Queen Bio, PBC Inc.	Level III	2	2	$114,000
Regeneron Pharmaceuticals, Inc.	Level IV	2	2	$194,185
Sanofi US Services Inc.	Level II	2	2	$91,978
Serif Biomedicines, Inc.	Level II	2	2	$92,500
Somite Therapeutics, Inc.	Level IV	2	2	$155,000
Takeda Development Center Americas, Inc.	Level III	2	2	$125,396
Tempus AI	Level I	2	2	$156,600
Tempus AI	Level IV	2	2	$494,300
Terrana Biosciences, Inc.	Level III	2	2	$117,889
TRUSTEES OF BOSTON UNIVERSITY	Level II	2	2	$94,400
TScan Therapeutics, Inc.	Level II	2	2	$100,000
University of Minnesota	Level III	2	2	$88,899
Vertex Pharmaceuticals Incorporated	Level I	2	2	$79,235
Vertex Pharmaceuticals Incorporated	Level IV	2	2	$135,486
Visterra, Inc.	Level II	2	2	$92,000

Tell me when this moves

One email when the prevailing wage for Molecular and Cellular Biologists in Boston-Cambridge-Newton, MA-NH changes — the library turns over every July, and what an employer must offer changes with it.

Source: OFLC disclosure data and prevailing wage library, US Department of Labor (public domain). Figures are what employers filed, not what they paid.